Mr. Majid Ali | Clinical Pharmacy | Outstanding Contributions in Academia Award
Lecturer Sulaiman Al-Rajhi University Saudi Arabia
đź“š Majid Ali is a highly accomplished pharmacy academic and clinical pharmacist with a distinguished career spanning teaching, research, and professional practice. He is a Fellow of the Higher Education Academy (UK) and actively contributes to the advancement of pharmacy education and healthcare.
Profile
Education
🎓 Education Highlights:
- Ph.D. (Ongoing): Artificial Intelligence in Higher Education, University of Malaysia, Malaysia (2022 – Present)
- MSc: Clinical Pharmacy, University of London, UK (2006 – 2007)
- BPharm: Pharmacy, Bahauddin Zakariya University, Pakistan (1999 – 2005)
Experience
👨‍🏫 Key Roles:
- Lecturer in Pharmacology: College of Medicine, Suliman Al-Rajhi University, KSA (2022 – Present)
- Lecturer in Clinical Pharmacy: University of Hertfordshire (Global Academic Foundation), Egypt (2021 – 2022)
- Adjunct Fellow: University of Adelaide, Australia (2018 – 2021)
- Clinical Pharmacist & Preceptor: King Abdullah Medical City, KSA (2015 – 2021)
- Numerous additional roles in academia, clinical pharmacy, and mentorship spanning multiple institutions worldwide.
Research Interests
🔬 Research Focus:
Majid Ali’s research interests include artificial intelligence applications in higher education, clinical pharmacy practices, diabetes management, interprofessional education, and pharmacotherapeutics.
Awards
🏆 Awards & Recognition:
- Tutor of the Year: Vice Chancellor Awards, University of Hertfordshire, UK (2012)
- GCC Pharmacy Awards (2nd Position): Dubai, UAE (2016, 2017, 2018)
- Faculty Quality Enhancement Award: Blended Learning Innovations, University of Hertfordshire, UK (2012)
Publications Top Notes:Â
đź“– Publications:
Majid Ali has authored several impactful studies in international journals, contributing significantly to pharmacy education and clinical practice. Key publications:
Personalised Learning in Higher Education for Health Sciences: A Scoping Review
The COX-2 Inhibitor that Went Wrong and Caused More Pain Than Relief: Valdecoxib